new drug pricing consensus letter, sign-ons requested.

NLM AIDSLINE New drug pricing consensus letter, sign-ons requested.
July 30, 1999

AIDS Treat News. 1998 Sep 4;(302):4. Unique Identifier : AIDSLINE Treatment activists are circulating a letter opposing drug-pricing strategies for abacavir (Ziagen) and efavirenz (Sustiva). The groups are concerned that these drugs will be priced significantly higher than other nucleoside analogs and non-nucleoside reverse transcriptase inhibitors. The statement notes that higher survival rates should insure drug manufacturers of a steady supply of patients, allowing them to lower prices and still make a profit. Both drugs are appropriate for treatment-naive and treatment-experienced patients, making the potential market for them large. The letter is sponsored by the Fair Price Working Group, which includes members from Project Inform, ACT UP/New York, the San Francisco AIDS Foundation, GMHC Treatment Issues, Foundation for AIDS and Immune Research, and AIDS Treatment News. Contact information is included. NEWSLETTER ARTICLE Anti-HIV Agents/ECONOMICS/THERAPEUTIC USE Dideoxynucleosides/ECONOMICS/THERAPEUTIC USE Economics, Pharmaceutical HIV Infections/DRUG THERAPY/ECONOMICS Human Oxazines/ECONOMICS/THERAPEUTIC USE Reverse Transcriptase Inhibitors/*ECONOMICS/THERAPEUTIC USE United States

Most Read: Latest Added Related Topics White House LGBT Conference on HIV/AIDS UNITED STATES: White House in Atlanta: LGBT AIDS Conference No more single-theme conferences: global HIV prevention conference planned FHI 360 Senior Scientist Lut Van Damme Receives International Microbicide Conference Lifetime Achievement Award Equatorial Guinea Ministry of Health and Social Welfare and UNICEF Refute Erroneous AIDS Prevalence Figures Photographs from A Day with HIV Now Online Bulgaria urges Libya to investigate AIDS nurses case Engineers enter fight against AIDS in Africa Gilead’s Complera® Non-Inferior to Atripla® Among Treatment-Naive HIV Patients UN chief Ban calls world leaders to end Aids by 2020 Positive living Lawyer: NY man at center of HIV scare not positive Zimbabwe activist: Prisoners denied AIDS drugs Youth organizations form a pact for social transformation in the AIDS response CountyCare Offers Historic Opportunity to Improve Care for People with HIV International AIDS Advocates Demand China Give $1 Billion to Global Fund Kingdom of Bahrain and UNAIDS commit to intensify cooperation CANADA: Celibate Homosexual Men Now Allowed to Donate Blood in Canada AFRICA: UN: AIDS Deaths Down, Treatment Up in Africa MICHIGAN: STD Fee for Jackson County Walk-In Clinic Takes Effect June 3 Zimbabwe activist: Prisoners denied AIDS drugs NEW YORK: Catskill Hospital Warns That Insulin Pens May Have Been Reused Blue Cross To Allow HIV/AIDS Patients to "Opt-Out" of Mandatory Mail-Order Rx Drug Program, Announces Consumer Watchdog CANADA: New Facility Unveiled for Homeless With Hepatitis C WALES: HIV Patients Are at Risk of Being Identified Because of New Prescribing System, Warns AM Study Finds Vitamin C Can Kill Drug-Resistant TB Big jump in HIV among Navajo in New Mexico Immune system cancer drugs tipped to be a $35 billion market UNAIDS reports more than 7 million people now on HIV treatment across Africa––with nearly 1 million added in the last year - while new HIV infections and deaths from AIDS continue to fall UNITED STATES: Navajo Confront an Increase in New H.I.V. Infections
Information in this article was accurate in July 30, 1999. The state of the art may have changed since the publication date. This material is designed to support, not replace, the relationship that exists between you and your doctor. Always discuss treatment options with a doctor who specializes in treating HIV.